Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2022 08:00 ET | Source: Mustang Bio, Inc.

Mustang Bio Announces City of Hope, University of Alabama at Birmingham and Nationwide Children’s Hospital Abstract Accepted for Late-Breaker Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022

WORCESTER, Mass., March 09, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in...
March 09, 2022 08:00 ET | Source: Sendinblue

Sendinblue Acquires Video Conferencing Scheduling Solution, MeetFox, Capitalizes on Growth Among SMBs

SEATTLE, March 09, 2022 (GLOBE NEWSWIRE) -- Sendinblue, the leading all-in-one digital marketing platform for small to medium-sized businesses, today announced its acquisition of the New York-based...
March 09, 2022 07:30 ET | Source: Protara Therapeutics

Protara Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Business Overview

- Phase 1 Study of TARA-002 in Patients with Non-Muscle Invasive Bladder Cancer Under Way - - Strong Cash Position of $130.7M as of December 31, 2021 Expected to Fund Operations into Mid-2024 - NEW...
March 09, 2022 05:38 ET | Source: Research and Markets

Global Commercial Laundry Machinery Market Report 2022: Market to Reach US$5.9 Billion by 2026 - Smart Laundry Equipment & Service Technologies Emerge Into the Spotlight

Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Commercial Laundry Machinery - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
March 09, 2022 04:10 ET | Source: InvestmentPitch Media and Nextech AR Solutions

InvestmentPitch Media Video Discusses Nextech AR Solutions, a Metaverse Company & Leading Provider of AR Products, and its Unaudited Financial Results for the Year Ended December 31, 2021

VANCOUVER, British Columbia, March 09, 2022 (GLOBE NEWSWIRE) -- Nextech AR Solutions Corp. (OTCQB:NEXCF) (NEO:NTAR) (CSE:NTAR) (FSE:N29), a Metaverse company and leading provider of augmented...
March 09, 2022 01:00 ET | Source: Wisekey International Holding SA

WISeKey’s WISeID Platform Helps Individuals and Companies Reduce Cybersecurity Risks

WISeKey’s WISeID Platform Helps Individuals and Companies Reduce Cybersecurity Risks WISeKey offers free access to cybersecurity services to anyone in need of protecting their digital assets GENEVA...
March 08, 2022 18:15 ET | Source: Biomea Fusion, Inc.

Biomea Fusion Announces Upcoming Presentations of Preclinical Data in Diffuse Large B-Cell Lymphoma, Multiple Myeloma, and Several KRAS Mutant Solid Tumors for BMF-219 at AACR Annual Meeting 2022

Irreversible covalent menin inhibitor, BMF-219, exhibited high potency and complete growth inhibition in high-grade B-cell lymphoma and multiple myeloma (MM) preclinical patient derived ex vivo...
March 08, 2022 17:32 ET | Source: 7 Hills Pharma

7 Hills Pharma’s Clinical-stage Novel Immunostimulant 7HP349 Granted FDA Fast Track Designation for Anti-PD-1-resistant Metastatic Melanoma

HOUSTON, March 08, 2022 (GLOBE NEWSWIRE) -- 7 Hills Pharma LLC (“7 Hills” or “7HP”), a clinical-stage drug development company bringing to market a platform of unique, first-in-class oral small...
March 08, 2022 17:30 ET | Source: Kura Oncology, Inc.

Kura Oncology Announces Multiple Abstracts Accepted for Presentation at AACR Annual Meeting

SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
March 08, 2022 16:05 ET | Source: Paratek Pharmaceuticals

Paratek Pharmaceuticals Announces the Publication of Data from an Investigator-Initiated Study of NUZYRA® (omadacycline) in a Hollow Fiber System Model Against Pulmonary Mycobacterium avium complex

BOSTON, March 08, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. announced today the publication of data from an investigator-initiated study evaluating the activity of NUZYRA®...